Brittany is a Patent Attorney in our Melbourne Chemistry team with a keen interest in commercialisation strategy and intellectual asset management. She utilises her knowledge in these areas to take a holistic approach to helping manage clients’ intellectual property portfolios.
Brittany has experience handling large patent portfolios for large multinational pharmaceutical and chemical companies including queries, prosecutions, assignments, licenses, amendments, and term extensions. She also provides infringement and validity, freedom to operate, and strategic patenting advice. Brittany is familiar with patent legislation in Australia, New Zealand, the United States, and Europe.
Prior to joining the intellectual property profession, Brittany worked with the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health in Bethesda, Maryland in the United States. While working with the Institute, she conducted research into the design and synthesis of antagonists of G protein-coupled receptors implicated in diabetes and obesity.
Her PhD at the Monash Institute of Pharmaceutical Sciences (MIPS) saw Brittany employ computational chemistry to design inhibitors of Plasmodium falciparum phosphodiesterase enzymes, synthesise these organic compounds in the laboratory, and biologically evaluate the compounds, which have demonstrated potent antimalarial activity. Brittany also worked as a Research Assistant at the Walter and Eliza Hall Institute of Medical Research, researching the synthesis of novel molecules as effective anti-cancer therapies.
Brittany undertakes considerable work in the chemistry industry as a RACI Victorian Committee Member and as a contributor to Chemistry in Australia and a number of IP blogs, journals and magazines.